Cite
HARVARD Citation
Wen, J. et al. (2021). Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model. Journal for immunotherapy of cancer. 9 (2), p. . [Online].